Prime Highlights: Ant Group plans to scale its healthcare business to match its payments and lending units within three years, using AI-powered digital health services to reach China’s 1.4 billion…
Prime Highlights: Iloilo City became the first Asian host of the Global Mental Health Advocacy Forum, welcoming experts from over 70 countries to discuss policy, financing, and rights. The forum…
Prime Highlights A Nipah virus vaccine developed by the University of Tokyo will start Phase 1 human trials in April, marking a major step in combating one of the world’s…
Prime Highlights: The Eye and ENT Hospital of Fudan University can now provide medical care on a specially equipped airplane. Doctors in Shanghai can guide the onboard medical team in…
Prime Highlight Chinese researchers found that the oral antiviral drug VV116 can strongly suppress the Nipah virus, offering hope where no approved treatments or vaccines currently exist. Animal trials showed…
Prime Highlights: Huahui Health’s libevitug becomes the first drug approved in China to treat chronic hepatitis D virus (HDV) infections. The antibody blocks HDV and hepatitis B virus (HBV) from…
Prime Highlight KMC Medical Centre plans to introduce an AI-powered MRI system to deliver faster, clearer, and more accurate diagnostic imaging for the Perak community. The initiative reflects a strong…
Prime Highlight Researchers created fully synthetic bacteriophages using digitally designed DNA to fight antibiotic-resistant bacteria. The method allows viruses to be safely and quickly reprogrammed for targeted treatments. Key Facts…
Prime Highlights: Indonesia and China have launched a joint laboratory to advance digital medicine, improve healthcare services, and strengthen Indonesia’s domestic medical industry. The partnership promotes local innovation and knowledge…
Prime Highlight Chinese made medicines and medical devices are seeing rising global acceptance, supported by record exports and international licensing deals in 2025. The export mix is shifting toward higher-value…
